Trial · NCT02864004
Registered outcomes26
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 26
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Difference in the Parkinson's Disease Quality of Life Questionnaire (PDQ39) summary index between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in the Patient Global Impression of Change (PGIC) | 12 months | |
| Secondary | Change in the Neurologist Global Impression of change (CGI-I) | 12 months | |
| Secondary | Change in non-motor aspects of experiences of daily living (MDS-UPDRS I) between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in motor aspects of experiences of daily in "on" and "off" medication (MDS-UPDRS II) between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in motor examination during "on" periods (MDS-UPDRS III) between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in motor complications with MDS-UPDRS IV between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in number of hours per day in the "best ON" state between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in number of hours per day in "ON" with dyskinesia between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in number of hours per day in "OFF" state between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in number of Sleeping-hours per day between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in Score of the Non-Motor Symptoms Scales (NMSS) for PD between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in psychosocial functioning PD (SCOPA-PS) between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Changes in score of depressive symptoms (BDI) between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in occurrence of anxiety (STAI-S) between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in pain assessed on the Visual Analog Scale (VAS) between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in cognitive function between the baseline assessment and the assessment at 12 months' follow up | 12 months | Change in cognitive function assessed by the Neuroscience Parkinson network's (NS-PARK) battery test |
| Secondary | Change in apathy assessed on the Apathy Scale between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in apathy assessed on the short version of Lille Apathy Rating Scale (LARS) between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change of dose for treatments assessed by levodopa (L-DOPA) equivalents between the baseline assessment and the assessment at 12 months' follow up | 12 months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02864004/registered